124 related articles for article (PubMed ID: 30593752)
1. Serum level of dipeptidyl peptidase-4 as a potential biomarker for medullary thyroid cancer.
Abooshahab R; Niyazi E; Yaghmaie P; Ghadaksaz HG; Hedayati M
Exp Oncol; 2018 Dec; 40(4):299-302. PubMed ID: 30593752
[TBL] [Abstract][Full Text] [Related]
2. Medullary Thyroid Carcinoma--Circulating Status of Vaspin and Retinol Binding Protein-4 in Iranian Patients.
Jabbari S; Hedayati M; Yaghmaei P; Parivar K
Asian Pac J Cancer Prev; 2015; 16(15):6507-12. PubMed ID: 26434866
[TBL] [Abstract][Full Text] [Related]
3. Lack of Association between Serum Adiponectin/Leptin Levels and Medullary Thyroid Cancer.
Abooshahab R; Yaghmaei P; Ghadaksaz HG; Hedayati M
Asian Pac J Cancer Prev; 2016; 17(8):3861-4. PubMed ID: 27644630
[TBL] [Abstract][Full Text] [Related]
4. The serum level of soluble CD26/dipeptidyl peptidase 4 increases in response to acute hyperglycemia after an oral glucose load in healthy subjects: association with high-molecular weight adiponectin and hepatic enzymes.
Aso Y; Terasawa T; Kato K; Jojima T; Suzuki K; Iijima T; Kawagoe Y; Mikami S; Kubota Y; Inukai T; Kasai K
Transl Res; 2013 Nov; 162(5):309-16. PubMed ID: 23994650
[TBL] [Abstract][Full Text] [Related]
5. Circulating dipeptidyl peptidase-4 activity is associated with insulin resistance in type 1 diabetic patients.
Blaslov K; Bulum T; Duvnjak L
J Diabetes Complications; 2015 Apr; 29(3):390-4. PubMed ID: 25641023
[TBL] [Abstract][Full Text] [Related]
6. Altered circulating concentrations of active glucagon-like peptide (GLP-1) and dipeptidyl peptidase 4 (DPP4) in obese subjects and their association with insulin resistance.
Ahmed RH; Huri HZ; Muniandy S; Al-Hamodi Z; Al-Absi B; Alsalahi A; Razif MF
Clin Biochem; 2017 Sep; 50(13-14):746-749. PubMed ID: 28288852
[TBL] [Abstract][Full Text] [Related]
7. Is DPP4 activity increased in PCOS?
Braga LDDC; Godoy-Matos AF; Siciliano PO; Corrêa JODA; Carvalho DP
Diabetes Metab Syndr; 2018 Sep; 12(5):673-675. PubMed ID: 29680519
[TBL] [Abstract][Full Text] [Related]
8. Increased hepatic expression of dipeptidyl peptidase-4 in non-alcoholic fatty liver disease and its association with insulin resistance and glucose metabolism.
Miyazaki M; Kato M; Tanaka K; Tanaka M; Kohjima M; Nakamura K; Enjoji M; Nakamuta M; Kotoh K; Takayanagi R
Mol Med Rep; 2012 Mar; 5(3):729-33. PubMed ID: 22179204
[TBL] [Abstract][Full Text] [Related]
9. Fasting serum dipeptidyl peptidase-4 activity is independently associated with alanine aminotransferase in type 1 diabetic patients.
Blaslov K; Bulum T; Knežević-Ćuća J; Duvnjak L
Clin Biochem; 2015 Jan; 48(1-2):39-43. PubMed ID: 25445232
[TBL] [Abstract][Full Text] [Related]
10. Dipeptidyl Peptidase 4 Activity Is Related to Body Composition, Measures of Adiposity, and Insulin Resistance in Subjects with Excessive Adiposity and Different Degrees of Glucose Tolerance.
Silva Júnior WS; Souza MDGC; Nogueira Neto JF; Bouskela E; Kraemer-Aguiar LG
J Diabetes Res; 2019; 2019():5238013. PubMed ID: 30886868
[TBL] [Abstract][Full Text] [Related]
11. Negative predictive value of procalcitonin in medullary thyroid carcinoma.
Lim SK; Guéchot J; Vaubourdolle M
Ann Biol Clin (Paris); 2016; 74(2):213-8. PubMed ID: 26806393
[TBL] [Abstract][Full Text] [Related]
12. Increased plasma dipeptidyl peptidase-4 activities are associated with high prevalence of subclinical atherosclerosis in Chinese patients with newly diagnosed type 2 diabetes: a cross-sectional study.
Zheng TP; Liu YH; Yang LX; Qin SH; Liu HB
Atherosclerosis; 2015 Oct; 242(2):580-8. PubMed ID: 26318108
[TBL] [Abstract][Full Text] [Related]
13. Association of plasma dipeptidyl peptidase-4 activity with non-alcoholic fatty liver disease in nondiabetic Chinese population.
Zheng T; Chen B; Yang L; Hu X; Zhang X; Liu H; Qin L
Metabolism; 2017 Aug; 73():125-134. PubMed ID: 28637594
[TBL] [Abstract][Full Text] [Related]
14. DPP4 activity is related to body weight and central fat in postmenopausal women.
Siciliano PO; Godoy-Matos AF; Braga LDDC; Denise Pires Carvalho J; Corrêa JODA
Diabetes Metab Syndr; 2019; 13(5):3031-3034. PubMed ID: 30030159
[TBL] [Abstract][Full Text] [Related]
15. Dipeptidyl peptidase 4 serum activity and concentration are increased in women with polycystic ovary syndrome.
Blauschmidt S; Greither T; Lampe K; Köller S; Kaltwaßer P; Behre HM
Clin Endocrinol (Oxf); 2017 Dec; 87(6):741-747. PubMed ID: 28799235
[TBL] [Abstract][Full Text] [Related]
16. Serum dipeptidyl peptidase 4 activity in children with type 1 diabetes mellitus.
Iwabuchi A; Kamoda T; Saito M; Nozue H; Izumi I; Hirano T; Sumazaki R
J Pediatr Endocrinol Metab; 2013; 26(11-12):1093-7. PubMed ID: 23817599
[TBL] [Abstract][Full Text] [Related]
17. Utility of proGRP as a tumor marker in the medullary thyroid carcinoma.
Parra-Robert M; Orois A; Augé JM; Halperin I; Filella X; Molina R
Clin Chem Lab Med; 2017 Mar; 55(3):441-446. PubMed ID: 27754959
[TBL] [Abstract][Full Text] [Related]
18. Plasma DPP4 Activities Are Associated With Osteoporosis in Postmenopausal Women With Normal Glucose Tolerance.
Zheng T; Yang L; Liu Y; Liu H; Yu J; Zhang X; Qin S
J Clin Endocrinol Metab; 2015 Oct; 100(10):3862-70. PubMed ID: 26259132
[TBL] [Abstract][Full Text] [Related]
19. Analytical Performance of a Gene Expression Classifier for Medullary Thyroid Carcinoma.
Pankratz DG; Hu Z; Kim SY; Monroe RJ; Wong MG; Traweek ST; Kloos RT; Walsh PS; Kennedy GC
Thyroid; 2016 Nov; 26(11):1573-1580. PubMed ID: 27605259
[TBL] [Abstract][Full Text] [Related]
20. Serum calcitonin negative medullary thyroid carcinoma: a systematic review of the literature.
Trimboli P; Giovanella L
Clin Chem Lab Med; 2015 Sep; 53(10):1507-14. PubMed ID: 25781697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]